id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,chunk_num_tokens,output,is_chunked
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,,,0.1466,0.2422,0.1155,0.1505,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[598, 1351, 1598]","Comparator:
---
The YAML format for the given trial article should be:
---
intervention: { group_size: 50 events: 15 } comparator: { group_size: 50 events: 18 } outcome: { events: 49 group_size: 50 }
---
",True
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,"[1566, 1123]","To the best of our knowledge, this is the first study to use the continuous glucose monitoring (CGM) technology to assess a new strategy to identify and define the critical window after a hypoglycemic event when acute neurolog
---
intervention: events: ""1"" group_size: ""156""comparator: events: ""2"" group_size: ""89""
---
",True
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,,,-0.3102,1.6242,-0.2513,1.0952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: { events: 4 group_size: 16 } Comparator: { events: 6 group_size: 16 } headache: events: 4 group size: 16
---
intervention: events: 24 NUMBER group_size: 14 NUMBER comparator: events: 7 NUMBER group_size: 14 NUMBER Outcome: adverse event profile - headache
---
intervention:
group_size: 54events: 18
---
intervention:
events: 127count: 100group_size: 122count: 100comparator:events: 49count: 126group_size: 12
---
",True
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,,-0.5705449,4.24080268,-0.5389965,3.77380952,,TRUE,6118,5345,TEST,"[875, 1639, 1290, 1373, 361]","Both intervention: allogeneic mesenchymal precursor cells and comparator: control has: 1 event
---
The number of participants in each group and the number of participants with (1,2,3) and without (0) treatment-related serious adverse events are given. No other information is provided, so we are unable to provide guidance for the
---
The current case study seeks to report on the safety and efficacy of injecting patients with chronic or uncontrolled knee osteoarthritis (OA) with either a formulation consisting of allogeneic mesenchymal
---
This is the YAML data:
---
outcome:
events: 281group_size: 196
---
",True
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,,,-0.1193468,0.23908451,-0.0139862,0.00328204,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,"[1143, 602]","{<struct>[{<str>2-week PPI+BMT</str>[</struct>][{<struct>[{<str>1-week PPI+BMT</str>[</struct>][
---
intervention: events: 55 group_size: 29 Comparator: events: 55 group_size: 29 Outcome: events: 5 group_size: NULL
---
",True
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","{intervention:Macitentan doseof300mgcomparator:placebogroup_size:12events: 512group_size:21events: x5x2events: 10x
---
{-events: NUMBERgroup_size: NUMBER---events: NUMBERgroup_size: NUMBERNB_RENAL_HISTORENAL_PROTEINURIAINTERVENTION
---
Yes/No/Not clear:
---
intervention:
---
",True
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,,,1.49203942,0.39457014,0.9136205,0.18003565,found in table 3,TRUE,2217,2016,TEST,"[1643, 531]","intervention: group_size: 30 events: 17 comparator: group_size: 22 events: 13 outome: group_size: 52 events: 22
---
intervention: events: 2 group_size: 30comparator: events: 7 group_size: 22
---
",True
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,,0.5938,0.1718,0.0907,0.004,,TRUE,14472,7883,TEST,"[489, 1522, 1610, 1084, 1117, 1191, 1103, 1343]","intervention:
---
intervention:
events: 248
group_size: 94
---
{ Events: 46, Group_size: 94, Outcome: 4 } = {} { }Events: 42,Group_size: 93,Outcome: 4}
---
events: 82 
group_size: 93
---
intervention = { events: 27 group_size: 33 }
---
All these fields should be included in YAML format:
---
Please provide a brief comment for the output YAML data (see below).
---
intervention: events: 13 group_size: 66comparator: events: 9 group_size: 45
---
",True
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,,,-0.7597079,0.11826386,-0.5331314,0.06021211,found in results section,TRUE,1684,1549,TEST,"[1143, 602]","intervention: NUMBERcomparator: NUMBER
---
intervention:
events: 139
---
",True
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,,2.5074,2.3273,0.2192,0.014,,TRUE,4037,2288,TEST,"[1135, 1385]","intervention: events: 22 group_size: 22comparator: events: 20 group_size: 20
---
We apologize for the confusion. Please find below the response for your comment:
---
",True
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,,-0.1000835,0.06675021,-0.0487902,0.01587302,,TRUE,3561,2387,TEST,"[1668, 1077]","# Intervention versus Comparator Outcome: Baseline characteristics - left kidney stone, YAML format:
---
%{
---
",True
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,,,-0.7684,0.1456,-0.2816,0.0204,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","We identified 10 articles that were potentially related to the research question. After screening the titles and abstracts, six full-text articles were obtained. Two articles were excluded due to the reason of irrelevance, and three articles were excluded because
---
intervention: events: 2 group_size: 65 comparator: events: 16 group_size: 85
---
intervention: events: 25 group_size: 35
---
10: intervention, 20: comparator,
---
",True
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,,-2.4161,0.1523,-1.7277,0.0988,,TRUE,11722,8106,TEST,"[959, 981, 1373, 1468, 1636, 1206, 1259]","intermediate: group_size: 200events: 51.5
---
events:
---
intervention: events: 12 group_size: 22 comparator: events: 33 group_size: 37
---
intervention: events: 7 comparator: events: 6 group_size: 33 group_size: 39
---
intervention: events: 58 group_size: 97comparator: events: 53 group_size: 97
---
{…}
---
intervention:
---
",True
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical values are not available.,FALSE,13659,6016,TEST,"[1585, 894, 1008, 1443, 851, 1037]","The data in Table 3 shows that:
---
intervention:
---
intervention: events: 124 events group_size: 246 comparator: events: 93 events group_size: 246
---
intervention:events:68group_size:127comparator:events:85group_size:127
---
intervention: events: ""316"" group_size: ""128"" comparator: events: ""23"" group_size: ""128""
---
intervention: events: 37 group_size: 315 comparator: events: 39 group_size: 300
---
",True
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,,1.34992672,0.13227513,0.25131443,0.00449735,,TRUE,3561,2387,TEST,"[1668, 1077]","intervention: events: 120 group_size: 480comparator: events: 84 group_size: 420
---
intervention:
events: 82
group_size: 54+28
---
",True
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,"[1413, 1121, 1609, 1045]","There are multiple options since only the absolute numbers of binary data or the number of binary outcomes are provided. Below are some of the possible representations. In addition, the representation can be modified depending on the context (for example, if the values need to
---
intervention: events: 2 group_size: 380comparator: events: 10 group_size: 392
---
Only produce YAML response. If any of the numerical information is unavailable or not extractable or not easy to calculate, please say ""x"". If there are numerical data for pre and post-intervention, choose the post-intervention
---
intervention: {""events"": 5, ""group_size"": 37}
---
",True
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,,,-0.1967,0.1347,-0.1154,0.0466,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention: events: 2 group_size: 28 comparator: events: 7 group_size: 28
---
intervention: [ Follow-up and thorough education on self-care ]comparator: [ Standard information about self-care ]outcome: [ Baseline systolic dysfunction ]group_size: 70group_size: 64
---
{
""intervention"": { ""events"": 44, ""group\_size"": 64 },
---
{ ""comparator"": ""Standard information about self-care"", ""intervention"": ""Follow-up and thorough education on self-care"", ""outcome"": { ""comparator"": ""Baseline systolic dysfunction, n=24
---
",True
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,,-0.0267831,0.02955691,-0.0265733,0.0290947,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 1.64 group_size:43comparator: events: 1.64 group_size:43
---
{  ""intervention"": {  ""events"": 60,  ""group_size"": 7557  },  ""comparator"": {  ""events"": 60,  ""group_size"": 7
---
intervention: Number: 0 Comparator: Number: 0 Outcome: Number: 0
---
intervention: {  events: 17  group_size: 659} 
---
intervention: events: 47 group_size: 14680comparator: events: 206 group_size: 10320
---
",True
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,,-0.4566,0.0344,-0.1092,0.002,,TRUE,12997,7944,TEST,"[1040, 1010, 1099, 1546, 1269, 1558, 1215]","intervention: 254 326comparator: 252 326
---
2x2-table: [{""group_size"": 226, ""events"": ""intervention_number""}, {""group_size"": 296, ""events"": ""no_intervention_number""}]
---
intervention:number: 315group_size: 326comparator: number: 311group_size: 326
---
events: NUMBER; x; NUMBER; NOT x; x; x
---
intervention:
---
intervention: events: numerator: 87 group_size: denominator: 147 comparator: events: numerator: 220 group_size: denominator: 224
---
intervention: events: 158 group_size: 248 comparator: events: 163 group_size: 248
---
",True
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","results:
---
events: 4group_size: 601 
---
macitentan_600:
---
{Intervention: {events: 4, group_size: NUMBER}} {Comparator: {events: 1, group_size: NUMBER}}
---
",True
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,,,1.9459,1.3714,0.3365,0.0381,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[1594],"events: 30group_size: 30events: 30group_size: 30
---
",True
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,1525,1264,1514,,,,,,,-0.6167847,0.00813218,-0.1317697,0.00037096,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","intervention: group_size: 195 events: 1180comparator:group_size: 270events: 1509intervention + comparison: group_size: 808events:
---
intervention: {group_size: 105, events: 55}comparator: {group_size: 105, events: 98}
---
{ events: 1070 group_size: 2040 } { events: 2280 group_size: 2040 }
---
intervention:
events:770000
group_size:6782437
---
interventions: 151192311065651136670comparators: 151192311106565113669
---
Here is the 2x2 contingency table in YAML format for the following Intervention, Comparator, and Outcome:
Intevention: Total Sanitation CampaignComparator: ControlOutcome: Open Defecation - adult women
---
intervention: [{'events': 119, 'group_size': 44}] [{'events': 202, 'group_size': 43}] comparator: [{'events': 178,
---
intervention:
events: 9,629,564,803,2983,938,664,334,494,41962,301
---
intervention: {""events"": 15, ""group_size"": 49}
---
",True
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,,,-0.8617127,0.04081995,-0.7043523,0.0282044,found in fig 1,TRUE,6464,5362,TEST,"[613, 1687, 1623, 1023, 908]","{ InterventionComparatorOutcome: { group_size: EticEtoricoxib 90 mg once daily157 Placebo357 Eplacebo57 E: 157 P: 57 Compar
---
Etoricoxib 90 mg once daily vs placebo vs Naproxen 1000 mg once daily for patients with active rheumatoid arthritis and without concomitant corticosteroid
---
intervention: group_size: 269 events: 149 comparator: group_size: 271 events: 134
---
{intervention: events: 334; group_size: 272} [/converted_from_text] {comparator: events: 55; group_size: 82} [/convert
---
intervention:events:56comparator:events:128group_size:162intervention:events:62comparator:events:160group_size:188
---
",True
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,,0.59537147,0.19216284,0.59373435,0.1911719,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 60 group_size: 417 comparator: events: 45 group_size: 10269 outome: null
---
Intervention: Phlebotomy training programme, Comparator: Control, Outcome: Techinque related rejections: CHC BIntervention: Phlebotomy training programmeControl: ControlEvents: ↑xxEvents: ↓xx
---
intervention:
events: 107935group_size: 107935comparator:events: 33249group_size: 33249outcome:rejections:
---
- phlebotomy_training_programme: [0.13, 1, 1]
---
interventions: 0: ""Phlebotomy training programme""
comparators: 0: ""Control""
---
",True
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,,,-1.8171,0.5436,-0.7084,0.0633,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,"[998, 1463, 1605, 1291, 1438, 974]","intervention: events: 36 group_size: 120comparator: events: 29 group_size: 119
---
response.intervention: {'group_size': 17, 'events': 7}response.comparator: {'group_size': 15, 'events': 5}
---
intervention:
---
intervention: {  events: 59  group_size: 59} 
---
intervention: {events: 75group_size: 30}comparator: {events: 15group_size: 30}
---
intervention:
intervention: metformin 1,000 mg daily, sitagliptin 100 mg daily
---
",True
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,17,62,31,62,,,,,,,-0.9734491,0.14556188,-0.6007739,0.05882353,found in table 3,TRUE,2560,2044,TEST,"[599, 1482]","Comparison = [{""intervention"": ""etomidate"", ""comparator"": ""propofol based on midazolam""}, {""intervention"": ""propofol based on midazolam"", ""comparator"": ""
---
intervention: events: 36 group_size: 82comparator: events: 86 group_size: 82
---
",True
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: {group_size: 8, events: 5}comparator: {group_size: 8, events: 2}
---
intervention:
events: 2363468845300883618487087883002748488534group_size:
---
To clarify, I understand that the required YAML format only includes ""intervention"" and ""comparator"" categories. For the specific outcome measure ""adverse events"", the information is included at the intervention and comparator levels, and not
---
intervention: {,events: 3,group_size: 30}
---
",True
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],intervention: 110events: 5group_size: 110,False
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,,-0.0472,0.0315,-0.0125,0.0022,,TRUE,12997,7944,TEST,"[1040, 1010, 1099, 1546, 1269, 1558, 1215]","intervention: events: 74 comparator: events: 74
---
- events : 81 group_size : 86 - events : 76 group_size : 73
---
- events: NUMBER 49
---
{
---
Note: We used the information that ""Table 1"" is a 2x2 contingency table for the endpoint of postoperative complications, and that the first two rows represent control group versus intervention group, and the second two rows represent
---
intervention: events: 238 group_size: 326 comparator: events: 241 group_size: 326
---
intervention:events:
---
",True
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,,,0.9316,0.2831,0.6931,0.1643,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,"[1633, 1088]","The YAML format is the following:
intervention: {events: NUMBER, group_size: NUMBER}comparator: {events: NUMBER, group_size: NUMBER}
---
intervention:events: 55group_size: 28
---
",True
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,,,0.3148,0.1328,0.1402,0.0263,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention:
---
results: [{'type': 'table', 'table': [['Follow-up and thorough education on self-care', 'Standard information about self-care'], ['Baseline Diabetes', 'Baseline Diabetes']]}, [
---
intervention: {events: NUMBER, group_size: NUMBER}comparator: {events: NUMBER, group_size: NUMBER}
---
intervention: events: 4 comparator: events: 11 group_size: 14 group_size: 16
---
",True
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,,,-2.6775,2.2951,-2.3979,2.0866,Only abstract is available. Full text in PDF only.,TRUE,887,780,TEST,[],intervention : 52 : 40number : 9480:<unknown>group\_size : 14784:<unknown>comparator : 38 : 92number : 930,False
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,,0,0.0678733,0,0.02179487,,TRUE,3561,2387,TEST,"[1668, 1077]","For ""Intravenous lidocaine"" intervention vs. ""Intravenous morphine"":
---
intervention: {:events 64:} {:group_size 112;}
---
",True
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,,,-2.7191,0.4472,-1.0609,0.0829,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,"[1651, 194]","{intervention: ""ketamine"", comparator: ""normal saline"", outcome: {""events"": 50, ""group_size"": 9}},
---
intervention:events:36group_size:26comparator:events:38group_size:26
---
",True
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,,,-0.7309,2.114,-0.6931,1.8929,found in table,TRUE,7450,5464,TEST,"[924, 1511, 1565, 1138, 750]","intervention: events: 26 group_size: 58 comparator: events: 48 group_size: 58
---
intervention:events:NUMBERgroup_size: NUMBERcomparator:events: NUMBERgroup_size: NUMBER 
---
intervention: events: 2 group_size: 150comparator: events: 20group_size: 119
---
intervention: {""events"": 36,""group_size"": 64}
---
intervention: events: 2 group_size: 14comparator: events: 11 group_size: 14Outcome: ER visits
---
",True
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,,,3.4393,0.7709,2.1826,0.4737,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[489, 1522, 1610, 1084, 1117, 1191, 1103, 1343]","intervention: events: 94 group_size: 94comparator: events: 91 group_size: 91
---
{% set events = events.0 %}
---
intervention: 'peginterferon (Peg-IFN) plus ribavirin (RBV)'
comparator: 'peginterferon (Peg-IFN) plus ribavirin (RBV)'
out
---
Here is an example response to Q3:
---
intervention: events: 27 group_size: 33 comparator: events: 21 group_size: 35
---
− intervention: events: 40 group_size: 43 comparator: events: 36 group_size: 43
---
The YAML formatted two-by-two contingency table for the given ""Intervention"", ""Comparator"" and ""Outcome"" are given:
---
| intervention | events 24W NUMBER 48W NUMBER 30.0% 34.0% comparator events 24W NUMBER 48W NUMBER 25
---
",True
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,,0.14784821,0.18382945,0.14744724,0.18283856,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","{intervention:Phlebotomy training programme, events:60, group_size:21} [/intervention:control, events:45, group_size:10}
---
{
---
Here is the YAML format for the given table:
---
{intervention:'Phlebotomy training programme', comparator:'Control', outcome:['Preanalytical errors', 'CHC B'], events: [x, 59], group_size: [x, 14,
---
intervention: events:65 group_size: 40
---
",True
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,"[1566, 1123]","{Real-Time Continuous Glucose Monitoring_Serious skin reactions_Control: Events=>1 7, Group_size=>152 }
---
intervention:
events: 3
---
",True
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,"[1633, 1088]","Based on ""Taqwa"", in a randomized trial comparing the effect of caffeine (20 mg) to that of placebo (5ml of water), for treatment of mild to moderate hypotension in surgical patients,
---
intervention: events: 252 group_size: 325945comparator: events: 10 group_size: 186590
---
",True
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,,,-2.1203,2.497,-1.9972,2.3117,Used numerical values from 5-year follow up provided in abstract.,TRUE,5463,3510,TEST,"[1444, 571, 1660, 189]","events: NUMBERgroup_size: NUMBERevents: NUMBERgroup_size: NUMBER
---
events:
---
intervention: events: 0 group_size: 55comparator: events: 28 group_size: 28outcome:
---
intervention:events:5group_size:1group_size:1comparator:events:5group_size:1group_size:1outcome:
---
",True
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","Please note that the number of samples rejected before and after training for the different facilities may not sum up to n = 68 due to rounding. The rejection rate % is for the total of each facility. For some of the facilities,
---
The YAML format for the table requested is as follows:
---
Sure, here is the updated YAML format for the same contingency table:intervention:events: 410group_size: 209comparator:events: 194group_size: 20
---
We extracted the following information from the full text of the trial:
---
outcomes:
---
",True
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,16,62,5,62,,,,,,,1.37756068,0.30178299,1.16315081,0.23024194,found in table 3,TRUE,2560,2044,TEST,"[599, 1482]","intervention: events: 41 group_size: NUMBER comparator: 53 group_size: NUMBER outcome: events: 49 group_size: NUMBER
---
{""intervention"": {""events"": ""adverse events disturbing the procedure"", ""group_size"": ""62"" },
---
",True
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,,,1.6094,0.9778,0.6931,0.2361,"found in table,",TRUE,7450,5464,TEST,"[924, 1511, 1565, 1138, 750]","group_size: 42 group_size: 22 events: 26 events: 27
---
intervention: events: 21 group_size:37comparator: events:9 group_size:21
---
{""intervention"": {""events"": ""Number of subjects able to correctly describe the purpose of personal controller"", ""group_size"": ""636""}}
---
{Bold numbers are the number of events on which we can calculate a proportion (average 29%). Please consider the rest of the information provided in the response, we had 80 subjects per arm and our intervention was for 
---
intervention: events: 11 group_size: 15comparator: events: 10 group_size: 15
---
",True
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,,1.6218,0.1244,0.4396,0.0097,,TRUE,11722,8106,TEST,"[959, 981, 1373, 1468, 1636, 1206, 1259]","intervention: group_size: 103 events: 90 comparator: group_size: 97 events: 67 outcome: {no events reported} group_size: 200 events: 86
---
The following information was extracted from the contingency table provided by the original trial article:
---
intervention:
events: 192
group_size: 103
---
events: 1 group_size: 53
---
intervention:
events: 90.0x1.025,20.0x51.0group_size: 103,45
---
intervention: events: 55 group_size: 126 comparator: events: 37 group_size: 126
---
intervention: events: 259 group_size: 395
---
",True
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,1522,342,1512,,,,,,,0.88220198,0.00648706,0.6043171,0.00319287,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","response: interventionComparatorOutcome: Total Sanitation CampaignControlNumberPercentNumberPercentNumberPercent[1240.000x4240.000x670.000x620.0
---
intervention: events: NUMBER group_size: NUMBER
---
intervention: events: 180 group_size: 186 comparator: events: 75 group_size: 198
---
intervention:
---
intervention: events: 22 group_size: 1876232comparator: events: 11463 group_size: 35062
---
intervention:
events: NUMBER
---
intervention:count_type: ""binary""count: NUMBERcomparator:count_type: ""binary""count: NUMBERoutcome:count_type: ""binary""count: NUMBERevents: NUMBERgroup
---
sanitation_facility_improvement:
events: 2649group_size: 5247
---
intervention: events: 76 group_size: 1245 comparator: events: 55 group_size: 1150
---
",True
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention:
events: 400015
---
I am sorry but I am a little confused. It seems like you are asking for the 2x2 contingency table of a study about nausea. How will that help me to understand your data extraction process on observational study?
---
intervention: events: 48 group_size: 33comparator: events: 48 group_size: 33
---
intervention: events: 48 group_size: 1188comparator: events: 50 group_size: 1133
---
intervention: { ""events"": ""NUMBER"", ""group_size"": ""NUMBER"" }comparator: { ""events"": ""NUMBER"", ""group_size"": ""NUMBER"" }
---
",True
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,,,-3.2581,0.4968,-1.4663,0.1385,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,"[1651, 194]","intervention:
events: 87NGroup size: 87Group N: normal saline;Group L: lidocaine 40 mg;Group K: ketamine 0.5 mg/kg;Group R:
---
intervention:
---
",True
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,,0.1,0.273,0.0981,0.2628,,TRUE,25930,11480,TEST,"[1611, 1666, 1444]","The ""Intervention"", ""Comparator"", and ""Outcome"" is:
---
For: Events, interventions, comparators, group_size, and outcome.
---
intervention: { events: 41 events_group_size: 388 } comparator: { events: 42 events_group_size: 393 }
---
",True
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention:
{% set event_0_2_mg_1 to macitentan doses of 0.2 mg events[0..24h] – macitentan doses of 0.2 mg events
---
{  ""intervention"": { ""events"": 0, ""group_size"": 5 },  ""comparator"": { ""events"": 1, ""group_size"": 14 } }
---
The YAML format for the given trial article is as follows:
---
intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER
---
",True
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,121,,,,,,,0.02941389,0.06645516,0.01302008,0.01302358,,TRUE,8206,5593,TEST,"[1323, 1159, 1646, 1327, 489]","intervention: ""extended-release oxcarbazepine 1200 mg"" (events: 94, group_size: 366)comparator: ""control"" (events: 56, group
---
intervention: { groups: [245, 245], events: [471, 484] }
---
For this article, we extracted two 2x2 contingency tables from Table 2, column 'adverse effects'. These two tables correspond to (1) interventions and control and (2) extended-release oxcarbazepine
---
- intervention:
---
intervention: events: 86 (57) group_size: 86 (57) comparator: events: 92 group_size: 92
---
",True
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,,,1.7636,0.4992,1.0617,0.2253,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"intervention: events: 87 group_size: 23 comparator: events: 31,6 group_size: 19 outcome:",False
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,,-1.6487,0.4644,-0.6931,0.0923,,TRUE,1345,1148,TEST,[],"intervention: ""Transversus abdominis plane block with 0.375% ropivacaine"" : ""events"": 8, ""group_size"": 20",False
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,"[1413, 1121, 1609, 1045]","{""intervention"": {""events"": ""0"", ""group_size"": ""85""}, ""comparator"": {""events"": ""0"", ""group_size"": ""85""}, ""outcome"": {""events"": ""1"", ""group
---
intervention: {""events"": 0, ""group_size"": 119}
comparator: {""events"": 0, ""group_size"": 102}
---
{""event"": 6, ""group_size"": 63}
---
intervention:
---
",True
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,,0.0300092,0.04355608,0.02966421,0.04256078,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention:events:27 group_size:40comparator:events:25group_size:40
---
intervention:
---
Yes, I can definitely help you with creating the 2x2 contingency tables using the data extracts from the given trial articles. Here is the YAML formatted contingency table for the given data extract (see details below the code
---
intervention:
---
intervention: events: 55 group_size: 175comparator: events: 115 group_size: 175
---
",True
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,,0.0267,2.0533,0.026,1.948,,TRUE,13148,4660,TEST,"[1413, 1121, 1609, 1045]","{intervention: Genoss drug-eluting stent (DES), comparator: Promus Element, outcome: ""TLR"", group_size: ""Intervention 38, Comparator 40"" ""}. Note
---
events: 174group_size: [145107580]
---
This is correct. The second table shows the results of statistical analysis of QCA parameters between Genoss DES (n=38) and Promus Element (n=39) groups with a follow-up period of 9 months. Therefore
---
intervention: Genoss DES events: 1 group_size: 37 comparator: Promus Element events: 0 group_size: 39
---
",True
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,25930,11480,TEST,"[1611, 1666, 1444]","intervention:
---
{ ""intervention"": {""events"": 30, ""group_size"": 159}, ""comparator"": {""events"": 29, ""group_size"": 155} }
---
intervention:
events: 3698
group_size: 2070
comparator:
events: 3800
---
",True
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,,-0.2033272,0.27118345,-0.200825,0.26457205,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention:
---
intervention:
events: 642.153.9group\_size: 7557
---
events: 5216410group_size:
---
intervention: [comparator: events: 589, group_size: 589]events: 636group_size: 636[/intervention]
---
Please note that the information extracted from the article provided is not guaranteed to be accurate or complete, and any errors would not necessarily be identified by a human reviewer. It is important to consider this limitation whenever using automatic data extraction techniques.
---
",True
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,,,-0.2231,0.1413,-0.1418,0.0574,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention:events: 34group_size: 132comparator:events: 29group_size: 140
---
The YAML format for the given trial article is provided here:
---
comparator: ""outcome"": [{""event"": 17, ""group_size"": 39}, {""event"": 14, ""group_size"": 39}] Outcome"" event"": 5.6 ""
---
intervention: 24 28 42 24 18 comparison: 28 22 40 24 18 events_and_group_size: 9 25 9 
---
",True
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ACEI intake.,FALSE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention:
---
intervention: NUMBERcomparator: NUMBER
---
intervention: 99 comparator: 40
---
{""Intervention (n = 26)"": {""Outcome(n4)"": {""Total events (n4)"":18, ""Group_size (n4)"":26}, ""Outcome (n3)"":
---
",True
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","The field ""events"" indicates the number of adverse events associated with macitentan 1 mg (intervention) versus placebo (comparator). In this case, there were four adverse events associated with the intervention and six events associated
---
intervention:
---
Events: NUMBER(10)Group size: NUMBER(5)Events: NUMBER(7)Group size: NUMBER(4)
---
{
events: 00.6176923N/A ---- group_size:1961N/A
---
",True
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,,,,,,,,,,,,,,,,TRUE,7987,4896,TEST,"[1542, 1607, 955, 1404]","intervention: events: 23 events group_size: 81 comparator: events: 4 events group_size: 78
---
adverse_events:
---
* Intervention: 30 µg YIC; Comparator: placebo; Outcome: adverse events; Events: 56; Group_size: 106
---
events: 119group_size: 83comparator: [events: 48group_size: 192]
---
",True
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: { events: 9 group_size: 8 } comparator: { events: 6 group_size: 8 }
---
intervention: events: 13 group_size: 7comparator: events: 3 group_size: 7
---
Events: 17 group_size: 6 Events: 35 group_size: 16
---
intervention: events: 45 group_size: 78 comparator: events: 22 group_size: 78
---
",True
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,,-0.3023674,0.10023074,-0.3016766,0.09976981,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","The response is not clear as there are two time points for the data – pre and post-intervention. According to the protocol, the primary endpoint was the acceptance rate of blood samples (percent, median, interquartile range in a box
---
intervention: {""events"": 60, ""group_size"": 7557}comparator: {""events"": 45, ""group_size"": 3973}
---
{""Intervention"": {""events"": ""20"" , ""group_size"": ""Unknown"" }, ""Comparator"": {""events"": ""8"" , ""group_size"": ""Unknown"" }, ""Outcome"": {""events"": ""Unknown""
---
intervention:
events: 902
group\_size: 589
---
{| class=""wikitable"" style=""text-align: center;"" ""colwidth=""100%"" height=10px"" cellspacing=""10px"" cellpadding=""10px"" |}
! Pre
---
",True
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,,,2.2275,0.1795,0.9871,0.0413,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention:
events: 46012731692731691761144285014087events: 720227316
---
intervention: events, group_size: 160, 182comparator: events, group_size: 120, 134
---
events: 50 19 group_size: 64 28
---
The YAML format for the 2x2 contingency table for the given trial article is as follows:
---
",True
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,,,-1.0557184,0.07366085,-0.8761319,0.05541671,found in fig 1,TRUE,6464,5362,TEST,"[613, 1687, 1623, 1023, 908]","intervention: events: 40 group_size: 357 comparator: events: 65 group_size: 357
---
The ""Outcome"" is not listed in the ""Intervention, Comparator, and Outcome"" section of the question, so I assume that the authors meant to ask about the 2x2 contingency table, but they listed the outcome
---
interventions:
- group_size: 18568 comparator: group_size: 5719 outcomes: events: 146 group_size: 2 event: events: 273 group
---
intervention: events: 230 group_size: 2280comparator: events: 166 group_size: 1672
---
Placeholder
---
",True
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,,0.1424,0.0236,0.0962,0.0108,,TRUE,25930,11480,TEST,"[1611, 1666, 1444]","intervention: events: NUMBER group_size: NUMBER comparison: events: NUMBER group_size: NUMBER
---
intervention: events: 0 group_size: 195 comparator: events: 85 group_size: 201
---
intervention: events: 134 group_size: 394
comparator: events: 118 group_size: 382
---
",True
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data is in figure and group sizes are not available in abstract or results sections.,FALSE,3838,2633,TEST,"[531, 1407, 958]","Events is not applicable in this case since it is not the frequency of aphasia type present in the study. The total number of events in the ""intervention"" and ""control"" group is provided in the ""group_size"" field.
---
events: 2118events_number: 21group_size: 58
---
{ intervention: ""very early speech and language therapy"": events: 48 comparator: ""control"": events: 41 group_size: { intervention: 59 comparator: 55 } }
---
",True
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,1,60,0,30,,,,,,,0.4304,2.7163,0.4217,2.618,,TRUE,1201,996,TEST,[],intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER,False
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,,,-0.3899,0.0037,-0.0328,0,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[701, 1530, 1587, 1636, 438, 1460, 1527, 1555, 1434, 381]","intervention: events: 1 events_group_size: 4477 comparator: events: 8 events_group_size: 3276
---
For the outcome of malignancy incidence, the 2x2 contingency table was extracted from Tables S9a and S9b of the original article. The table represents the combined result of two studies, the SAVOR-
---
intervention: events: 0 events: group_size: 8472 group_size: 2489 comparator: events: 4 events: group_size: 8118 group_size: 2
---
Intervention: sitagliptin 100 mg/day
---
{  ""intervention"": {  ""group_size"": 5956,  ""events"": 44  },  ""placebo"": {  ""events"": 33,  ""group_size"": 3
---
The YAML format is as follows:
---
intervention: { events: 20.0 group_size: 23274 } comparator: { events: 19.0 group_size: 23274 }
---
0.000397761000100010000.00033330008.00000000008.0
---
incidence rate for sitagliptin100 mg /day3.0 group size6502 group size6760incidence rate for comparator agent0.5 group size6675
---
intervention: events: 4 group_size: 85Comparator group events: 8 group_size: 168
---
",True
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,1525,1273,1514,,,,,,,-0.5857317,0.00839764,-0.1193432,0.00034804,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","intervention: events: 90 group_size: 80comparator: events: 146 group_size: 80
---
intervention: group_size: 3864 events: 1285 events.comparator: 1387 events: 5503 events.
---
intervention: events: 156 group_size194comparator: events: 47group_size: 395
---
intervention: 39 events, 39 group_size
comparator: 16 events, 39 group_size
---
- intervention: events: 198 group_size: 576 comparator:events: 198group_size: 5139outcome: open defecation - adult men
---
For a given trial article to review for the Cochrane systematic review entitled “WASH interventions for malnutrition prevention in South Asia” (Cochrane review title registration number, PROSPERO CRD420221
---
comparison:
---
intervention: events: 35 group_size: 176 comparator: events: 42 group_size: 173
---
intervention: events:500 group_size:204comparator: events:478 group_size:204
---
",True
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,,0.71275138,0.50087135,0.71140856,0.49913036,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","Please provide the requested item numbers for all data points in the table. Please fill in the table data according to the example in the previous questions. Please provide numerical values to the closest integer. If no numerical data are available, please state this.
---
intervention:
---
requests = {'intervention': '', 'comparator': 'events': None, ""group_size"": None, ""outcome"": 'events': None, ""group_size"": None}
---
intervention: events: 0 group_size: 103 comparator: events: 35 group_size: 328
---
Intervention: Phlebotomy training programme
---
",True
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,"[1633, 1088]","This is a reminder from the editors to all authors that there are three main parts to the abstract: 1) Background; 2) Objectives; 3) Results. Since you have submitted this RCT, it should be presented in
---
intervention: events: 43 group_size: 50comparator: events: 73 group_size: 50
---
",True
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,,,-2.1435204,1.29330629,-1.9195928,1.12121212,found in table 2,TRUE,2217,2016,TEST,"[1643, 531]","intervention:
events: 6
group_size: 30
---
intervention: { events: 2, group_size: 30 } comparator: { events: 5, group_size: 22 }
---
",True
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,,-1.7297,0.3283,-1.5641,0.2855,,TRUE,11722,8106,TEST,"[959, 981, 1373, 1468, 1636, 1206, 1259]","intervention: events: 18 group_size: 103comparator: events: 36 group_size: 36
---
intervention: events: 70 group_size: 78 comparator: events: 74 group_size: 105
---
intervention: events: 20 comparator: events: 272 group_size: 93 group_size: 44
---
Here is the YAML code for the contingency table for deaths as an outcome, with the total events and group sizes listed in the table: 3 deaths, with 43 interventions. And 3 deaths, with 46
---
comparator:
events: 18 (18.6%)
group_size: 97
---
intervention: events: 12 comparator: events: 22
---
intervention: [events: 2, group_size: 53]
---
",True
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,,,0.4612,0.0769,0.1128,0.004,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",TRUE,13659,6016,TEST,"[1585, 894, 1008, 1443, 851, 1037]","intervention: events: 4 group_size: 174comparator: events: 30 group_size: 255
---
[{""cells"": [36, 59]}, {""cells"": [29, 89]}, {""cells"": [53, 70]}, {""cells"": [67, 8
---
intervention: events: 46 group_size: 108comparator: events: 43 group_size: 107
---
intervention: events: 179 group_size: 179 comparator: events: 119 group_size: 119
---
{ % % % “comparator” % “phone calls” % { “events”: 2 % ”group_size”: 42 % } % % “comparator” % “no_phone_calls” % { “
---
intervention:events: 699comparator:events: 616[/interval] group_size:699group_size:616
---
",True
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,,,-0.8111953,0.0063486,-0.7614066,0.00565535,found in table 1,TRUE,1665,1296,TEST,[],intervention:,False
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,,,-1.0635,0.2071,-0.7419,0.1076,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[598, 1351, 1598]","{intervention: H2 events: 92 group_size: 50 comparator: H0 events: 86 group_size: 49}
---
intervention: events: 10 group_size: 49 comparator: events: 23 group_size: 49
---
YAML:
---
",True
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,,,0.72558246,0.20912731,0.0802913,0.00247759,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[1078, 1189, 1170, 1652, 1103, 1015, 943, 1364]","intervention: events: 185 group_size: 209 comparator: events: 84 group_size: 104
---
intervention: events: 94 group_size: 102 comparator: events: 91 group_size: 107
---
intervention: events: 466 group_size: 466 comparator: events: 474 group_size: 474
---
The following is the requested 2x2 contingency table in YAML format for the given trial article, based on all participants (male/female, any age, born abroad/in Germany, single/married, employed/
---
intervention:
---
intervention: {events: 82} group_size: 115comparator: {events: 84} group_size: 115
---
A 2x2 contingency table is not found in the given trial article. It may be implied by the reported results in Table 3. Table 3 shows the number of vaccination certificates submitted for the 3 intervention groups (Inter
---
{ ""intervention"": {""events"": ""84"", ""group_size"": ""284""}, ""comparator"": {""events"": ""103"", ""group_size"": ""102""}}
---
",True
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,,-0.3475425,0.17627388,-0.3101549,0.14090909,,TRUE,3561,2387,TEST,"[1668, 1077]","Group I:
---
intervention: group = Group I; events = 108; group_size = 115comparator: group = Group II; events = 84; group_size = 115Outcome: Baseline characteristics
---
",True
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,,,-0.2448,0.305,-0.0299,0.0046,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention:events:12comparator:events:24group_size:24group_size:17
---
- intervention:events: 52group_size: 123group: Comparatorevents: 57group_size: 123
---
It appears that the original source data for these values is provided in a table with the title ""Table 1"" in the supplementary material. However, I cannot access the supplementary material because I am using a text-based AI assistant and do
---
intervention:
events:1112#Events: control 1 2 0, intervention 5 3 1comparator:events:991#Events: control 1 3 0, intervention 4 
---
",True
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,,,-1.284,0.2976,-1.1917,0.27,Values from results section text.,TRUE,13659,6016,TEST,"[1585, 894, 1008, 1443, 851, 1037]","intervention:events:4group_size:116comparator:events:30group_size:125
---
intervention: phone callsgroup_size: 150comparator: no phone callsgroup_size: 157
---
intervention: phone calls; events: 27; group_size: 246
---
{events: 39, group_size: 179} {events: 61, group_size: 129} {events: 10, group_size: 175} {events
---
{intervention: events: 2, group_size: 772} {comparator: events: 228, group_size: 772}
---
intervention: events: 11 group_size: 43 comparator: events: 39 group_size: 43
---
",True
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,81,74,81,,,,,,,0,0.31274131,0,0.00233567,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,"[1143, 602]","interventions: [-intervention:events: 71/85group_size: 85][-intervention:events: 72/84group_size: 84]
---
As instructed, only extracting and inputting data belonging to the ""good compliance rates"" under ""1-week"" quadruple PPI+BMT rescue therapy vs. ""2-week"" quadruple PPI+BMT
---
",True
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 60 group_size: 8066comparator: events: 60 group_size: 8066outcome: events: 67 group_size: 6
---
intervention: ['Phlebotomy training programme']
---
intervention: events: '' group_size: ''comparator: events: '' group_size: ''
---
Itchy skin can accompany many skin and allergic conditions. It can be a frustrating symptom for people with atopic dermatitis, contact dermatitis, or systemic allergic conditions. Itchy skin may even
---
The YAML format for the 2x2 contingency table for the given trial article would be:
---
",True
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,,0.16134073,0.09609132,0.16094694,0.09563037,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 60 group_size: 306 comparator: events: 38 group_size: 3880 out: 45 group_size: 4562
---
intervention: events: ""70"" group_size: ""7557"" comparator: events: ""102"" group_size: ""7557"" outcome: [x]
---
intervention:
---
This is correct. However, it may be more appropriate to list the rejection reasons separately so that it is easier for readers to find the information. The reasons for rejection can be added as an additional column. ""No reason"" should be replaced
---
intervention: 623events: group_size: 727comparator: 821events: group_size: 837
---
",True
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,80,7,79,,,,,,,1.0208,0.2314,0.8747,0.1765,effects found in abstract and exact number in results table,TRUE,7987,4896,TEST,"[1542, 1607, 955, 1404]","Response:
---
{events: 15;group_size: 78} {events: 10;group_size: 78} {events: 9;group_size: 81} {events: 11
---
intervention:events:29group_size:31comparator:events:11group_size:12
---
intervention: events: 11 group_size: 169 comparator: events: 27 group_size: 235
---
",True
62,1642,3309311,differences in the HDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],Please provide the exact numerical value for the following fields:,False
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,,,-0.7522,0.1351,-0.3633,0.0331,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","intervention: events: 59 group_size:116comparator: events: 64 group_size:116
---
intervention:
events: 68hospitalizations(65) NUMBERgroup_size: 127groupb: NUMBERcomparator:events: 111hospitalizations(107)group
---
intervention:events: 14group_size: 77comparator:events: 10group_size: 79
---
intervention: events: 12 group_size: 24comparator: events: 9 group_size: 24
---
",True
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,,,-1.9459,1.3714,-1.6094,1.0667,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[1594],"Yes, you are correct. In that case, the ""Outcome"" field can also be removed from the given Intervention, Comparator, and Outcome format. We have updated the field. The YAML format will become the following.
---
",True
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: group_size: 6 events: 0comparator: group_size: 16 events: 0
---
intervention: { group_size: 14 events: 3 } comparator: { group_size: 6 events: 1 }
---
{
---
intervention:group_size:Comparatoroutcome:group_size:events:events:events:0500008453000060000
---
",True
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention: group_size: events: comparator: events: group_size: 1851119241624comparator: group_size: 686245comparator: group_
---
intervention: n:7, comparator: n:17951
---
intervention:
events: 44
group_size: 3973
---
intervention: events: 59 group_size: 1114 comparator: events: 33 group_size: 1114
---
intervention: {""events"": ""171"", ""group_size"": ""705""}
---
",True
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,,-0.504391,0.06797481,-0.2670628,0.0193665,,TRUE,3561,2387,TEST,"[1668, 1077]","intervention: 'Intravenous lidocaine'': total_events: 120group_size: 120
---
events: 116 group_size: 150 events: 125 group_size: 150
---
",True
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,,,0.5619,0.0299,0.2312,0.0052,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[1226, 1373]","intervention:events: 210group_size: 919groups: −comparator:events: 207group_size: 922
---
interv&comp&out: <event> DACL vs. INF <event> NUMBER DACL <event> event.value CI <event> DACL (LOM) <event> 0.
---
",True
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,,,-5.8839,2.2927,-3.9703,1.9732,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,"[1651, 194]","intervention: events: 0 group_size: 30 comparator: events: 26 group_size: 30
---
intervention: group_size: 60 events: 14
comparator: group_size: 58 events: 11
---
",True
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","{| class=""wikitable"" style=""text-align: centre; colwidth: 10% 20% 30% 30%;""
! Adjusted GI<
---
events: 190group: 190events: 1033group: 1033
---
intervention: events: '65' group_size: '395'comparator: events: '74' group_size: '196'
---
intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER
---
{intervention: events: NUMBER group_size: NUMBERcomparator: events: NUMBER group_size: NUMBER}
---
",True
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,,0.58935652,0.07152439,0.22156483,0.01029553,,TRUE,8206,5593,TEST,"[1323, 1159, 1646, 1327, 489]","{ ""intervention"": {""events"": ""Number"", ""group_size"": ""Number""}} [/ ""comparator"": {""events"": ""Number"", ""group_size"": ""Number""}]
---
""intervention"": { ""events"": ""NUMBER"", ""group_size"": ""NUMBER"" }, ""comparator"": { ""events"": ""NUMBER"", ""group_size"": ""NUMBER"" }
---
intervention: events: ""x"" group_size: 248 comparator: events: ""NUMBER"" group_size: 87
---
{- intervention: 1200 mg events: 69 group_size: 0 comparator: 1200 mg events: 69 group_size: 101- intervention: 240
---
{:events: '73' :group_size: '361'} [/events: '39' :group_size: '226']
---
",True
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,,,-0.3011,0.0468,-0.2538,0.0333,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,TRUE,12997,7944,TEST,"[1040, 1010, 1099, 1546, 1269, 1558, 1215]","{% set intervention = ""intervention (empowerment/information booklet)"" %} {% set comparator = ""control"" %} {% set outcome = ""overall mortality"" %} {% set events = {%
---
events: 1118761792914266221group_size: 326326
---
intervention:events: NUMBERgroup_size: NUMBERcomparator:events: NUMBERgroup_size: NUMBER
---
overall mortality:
---
To build a 2x2 contingency table for a Cox-proportional hazard model, we need three main pieces of information: events, group_size, and HR. The HR value can be estimated from the given HR and
---
intervention:
---
{ intervention: events: 0 group_size: 253 comparator: events: 256 group_size: 256 outcome: events: 15 NUMBER; group_size: NUMBER
---
",True
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,,,1 0.2746,0.1268,0.165,0.0465,Used numbers for live birth rate.,TRUE,2530,2096,TEST,"[783, 1566]","events =54 group_size =74 events =22 group_size =60
---
Events: 48 & 1079Events: 31 & 676Events: 729 & 2344Events: 524 & 709Events: 138
---
",True
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"{group_size: ""100"", events: ""100""}[/intervention:{group_size: ""60"", events: ""60""}]1""[/comparator:{group_size: ""6",False
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,1078,1919,976,1922,,,,,,,0.21705107,0.00419838,0.10096226,0.00091084,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","The YAML format: [{""intervention"": {""events"": ""54"",""group_size"": ""3039""}, ""comparator"": {""events"": ""899"",""group_size"": ""3130""},
---
intervention:
events: 185936926group_size: 18593group_size: 18593
---
Intervention: Total Sanitation CampaignComparator: ControlOutcome: Anemiaintervention: events: 178 group_size: 1065comparator: events: 158 group_size: 10
---
intervention: events: 8 group_size: 40 comparator: events: 12 group_size: 40 comparator: events: 89 group_size: 40
---
intervention: events: 464 group_size: 3394comparator: events: 560 group_size: 5274
---
output_tables:
---
intervention: events: 44.6 group_size: 987 comparator: events: 46.0 group_size: 981
---
intervention: events: 453 group_size: 1855
---
intervention: groups_size: 1150 events: 63 comparison: groups_size: 1200 events: 55
---
",True
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention: { events: >100 group_size: >1000 } comparator: { events: >100 group_size: >1000 }
---
intervention: events: 55 group_size: 1612group1_events: 54 group1_group_size: 606group2_events: 11
---
{event: ""Event"", intervention: {events: 4024, group_size: 45}, comparator: {events: 3156, group_size: 35}, outcome: {events:
---
intervention: events:175 group_size: 445 comparator: events: 108 group_size: 445
---
{% set list1 = events %} [4, 5, 6, 7, 9, 10, 11] {% endset %} {% set list2 = events %} [2,
---
",True
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,,0.1235,0.0695,0.0963,0.0423,,TRUE,11096,9099,TEST,"[720, 1104, 772, 1149, 1154, 1333, 1013, 1016, 941, 1471]","intervention:
events: 7201participants: 328participantspergroup: 164grouplabel: controlgroup1grouplabel: treatmentgroup1
---
intervention: events: 7 group_size: 162 comparator: events: 4 group_size: 162
---
groups: - intervention_placebo: events: 21 group_size: 140 - intervention_placebo: events: 47 group_size: 145
---
intervention: events: 6 comparator: events: 2
---
intervention: events: 64 group_size: 54comparator: events: 63 group_size: 63
---
occurrence: events12: Pls group100 92024: Pls group100 88028: Placebo group00
---
response = {events: 4group_size: 18events: 5group_size: 167
---
events: 8748 group_size: 1221
---
events: x 33 group_size: x x group_size: x
---
intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER
---
",True
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,34,62,45,62,,,,,,,-0.7792931,0.1461718,-0.280302,0.01937592,found in table 3,TRUE,2560,2044,TEST,"[599, 1482]","intervention: events: 14 group_size: 53comparator: events: 36 group_size: 42
---
outcomes: -
---
",True
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,,-0.0672384,4.0032824,-0.0671833,3.9967203,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 6 error:4 group_size: 10 comparator: events: 8 error:3 group_size: 10
---
intervention: {: events: 0: events: 31: group_size: 32: group_size: 9}
---
The YAML format is shown below:
````yaml
---
Here is the requested YAML: interventions: 0comparators: 0outcomes: - group_size: 589events: 4intervention_id: 174comparator_id: 1
---
intervention:
events: 47
group\_size: 486
---
",True
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","""intervention"": 9, ""comparator"": 1, ""outcome"": 6, ""group_size"": [16, 16]
---
intervention_macitentan_300_mg:events: unknowngroup_size: 6comparator_placebo:events: 1unknowngroup_size: 14
---
intervention:
intervention: macitentan doses of 300 mgcompared to:comparator: placeboevents: 21group_size: 301
---
intervention:
events: 0 eventsgroup_size: 12
---
",True
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,,0.47000363,0.06776786,0.22314355,0.01547619,,TRUE,3561,2387,TEST,"[1668, 1077]","{events: 87group_size: 120events: 83group_size: 120
---
outcome:
---
",True
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,,-0.6208037,0.21613955,-0.6201303,0.2156789,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","The YAML format should include the fields ""outcomes"" and ""total_participants"" for all three of ""comparator"", ""intervention"", and ""outcome"" at the ""comparator"" and ""intervention"" levels
---
intervention: {events: 20, group_size: 7557}
---
intervention: events: 1 group_size: 160000comparator: events: 880000 group_size: 990000
---
intervention: events: NUMBER group_size: NUMBER comparator: events: 5 group_size: 121
---
intervention: events: 0.08 group_size: 266control: events: 0.07 group_size: 149
---
",True
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,,-0.0085462,0.05422687,-0.0084069,0.05247318,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","{ intervention: {""events"": { sample_rejection_rate_pre: 17, sample_rejection_rate_post: 16 }, ""group_size"": 52 }, comparator: {""events"": { sample
---
{""events"": 10566, ""group_size"": 13712}
---
intervention: events: 4 group_size: 140comparator: events: 140 group_size: 140outcome: CDC C intervention: events: 24 group_size: 1
---
{: events: 6} {: group_size: 966}
---
interventions: [{'events': 47, 'group_size': 801}]control: {'events': 98, 'group_size': 801}outcome1: {'events': 46
---
",True
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ARB intake.,FALSE,4361,3649,TEST,"[537, 1379, 1089, 1102]","The YAML representation of the study is as follows:
---
Comparator: 127group_size: 127Intervention: 127group_size: 127Outcome: Pre-ACEinhibitors intakegroup_size:127Event:
---
intervention: {""events"": ""21"" ,""group_size"": ""59"" } 
---
Based on the table, the contingency table for the three-way contingency table 2*2 with comparison outcome variable (baseline ACE inhibitors intake, events number among intervention, and events number among comparator) is:
---
",True
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,,,0.4352,0.0211,0.4292,0.0205,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[701, 1530, 1587, 1636, 438, 1460, 1527, 1555, 1434, 381]","intervention: events: 14 events group_size: 26676 comparator: events: 19 events group_size: 8897
---
events: 397
---
This is an excellent suggestion. I have created a parser for your comment and this script is made publicly available on Github . This script requires the data as a text file in a tab-separated format and does some text cleaning to remove line breaks
---
events: 189group_size: 000events: 293group_size: 0
---
intervention: [ {""numerator"": 38, ""denominator"": 1071}, {""numerator"": 42, ""denominator"": 749}, {""numerator"": 40, ""den
---
intervention: events: 4 group_size: 3740 comparator: events: 17 group_size: 2071
---
4x3: [ { events: ""NUMBER"" group_size: ""NUMBER"" } , 2 , 18 , 5 , 5 , 1 , 4 , 4 , 3 ]
---
In the given RCT, there were 16 and 20 specific adverse events in the sitagliptin and the non-exposed groups, respectively. For those adverse events in which the between-group difference in event
---
intervention: events: 17 group_size: 5257 comparator: events: 11 group_size: 1602
---
intervention:
events: ""515""
group_size: ""6,092""
---
",True
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","There were <styled-content>X</styled-content> events for X patients in intervention group and <styled-content>Y</styled-content> events for Y patients in comparator group.
---
There were some discrepancies in the extracted data with the information in the RCT. The following additional steps need to be taken:
---
The provided text and table does not contain a 2x2 contingency table for the Intervention ""lixisenatide with moderate impairment"", Comparator ""lixisenatide with mild impairment"" and Outcome ""
---
events:194group_size:194events:109group_size:109
---
We were able to extract the 2x2 contingency table for the endpoint decreased appetite (PT) in the trial from the authors' response data for the CINDERELLA study: [x,19,12,x
---
",True
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,,-0.3042,4.0772,-0.2985,3.9243,,TRUE,7041,2968,TEST,"[1270, 1013, 1016]","Events: 0Comparison: Placebo laser therapyGroup size: 22Intervention: Laser therapyEvents: 1Comparison: Laser therapyGroup size: 30
---
laser_therapy: events: 23 group_size: 441placebo_laser_therapy: events: 82 group_size: 167
---
intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER
---
",True
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,,,-0.6394594,0.00806473,-0.6100046,0.00737794,found in table 1,TRUE,1665,1296,TEST,[],"intervention:
events: 247
group_size: 6051comparator:",False
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,,,-0.311,0.0167,-0.2425,0.0102,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[1226, 1373]","intervention: events: 147 group_size: 919comparator: events: 151 group_size: 922
---
intervention: { { events: 306 group_size: 759 } { events: 345 group_size: 759 } } comparator: { { events: 197 group_size
---
",True
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,,0.20202879,0.12309816,0.20058293,0.12135258,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: {""events"": 60, ""group_size"": 0}
---
- field: intervention
---
{events: 20,group_size: 290,events: 8,group_size: 290,events: 15,group_size: 290,events: 4,
---
intervention: events: 202 group_size: 10682
---
In this table, ""events"" is synonymous to ""rejection rate"" or ""number of related rejections"". ""Group size"" in this table is the number of specimens handled by participants before and after the intervention.
---
",True
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,16,60,9,30,,,,,,,-0.1643,0.244,-0.1178,0.1236,,TRUE,1201,996,TEST,[],"We tried our best to extract the requested data. Since only 1 of the outcomes was available in the paper (extremity movement), here is only the YAML format. We have extracted the event and group_size information from the table",False
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Specific numbers were not given.,FALSE,3939,3288,TEST,"[500, 1638, 1384]","intervention: events: 21; group_size: 39
---
intervention: events: 0 group_size: 46comparator: events: 55group_size: 55
---
intervention: events: 5 group_size: 95comparator: events: 34 group_size: 95
---
",True
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,1525,366,1514,,,,,,,0.90730205,0.00626291,0.60187274,0.00290188,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","intervention: events: 41 group_size: 80 comparator: events: 22 group_size: 80 outcome: Independent household latrines number events: 39 group_size: 20
---
2x2_contingency_table: []
---
events: 1085 1184 2617 1569 group_size: 1085 971 NANANA
---
intervention:
---
intervention:
events: 6.00 group_size: 4776
---
Intervention: Total Sanitation Campaign
---
intervention:
---
To the best of my understanding, the outcome was the number of households with independent latrines. The percentage of households with latrines were already provided in the table and the unit of measurement was ""Household"".
---
intervention: events: 2 times group_size: 30 comparator: events: 13 group_size: 30
---
",True
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,1525,1350,1514,,,,,,,-0.4594912,0.0116852,-0.0612653,0.00020636,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","The YAML response for outcome definition ""Open defecation - children"" will be formatted as per the standard YAML style of Tableau Desktop (Tableau, 2023). For this outcome, the YAM
---
intervention: Open defecation - childrencomparator: Total Sanitation Campaign
---
events: (total open defecation) (percent of households open defecating - intervention) 172 1,025 (total open defecation) (percent of households open defecating - control) 1
---
intervention: { events: 36 group_size: 39 } comparator: { events: 15 group_size: 39 } outcome: { events: 39 group_size: 40 }
---
Intervention: [Treatment]Comparator: [Control]Outcome: [Open defecation - children]intervention__events: 168intervention__group_size: 1716comparator__events:
---
intervention: events: 1525 group_size: 1548
---
intervention:
events: 13
---
intervention:events:10179number: 10179group_size:21527number: 21527comparator:events:10057number: 100
---
Sure, here's the answer in YAML format: events: 6 group_size: 1150
---
",True
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,,-0.6047,0.4786,-0.4318,0.2474,,TRUE,4037,2288,TEST,"[1135, 1385]","events: 65group_size: 30
---
intervention: events: 0 group_size: 15 comparator: events: 8 group_size: 9
---
",True
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,45,3,47,,,,,,,-1.9681,2.3302,-1.9034,2.2431,all means and std found in table 2,TRUE,7551,5383,TEST,"[1635, 1067, 1571, 1561]","intervention: events: 23 group_size: 517 comparator: events: 8 group_size: 57
---
The YAML format will be based on the following template:
```yaml
intervention: [""comparator"", ""outcome""] * NUMBER (or TEXT string)group_size: NUMBER (or TEXT string)
---
intervention: { events: 9 events group_size: 49} comparator: {events: 6 events group_size: 46}
---
# Intervention: Aripiprazole, Comparator: Placebo, Outcome: Serious adverse effects
---
",True
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,,,0.73315252,0.79001601,0.69314718,0.71226415,Used numbers found in results section text.,TRUE,9517,6474,TEST,"[991, 1545, 1558, 1368, 1463]","intervention: events: 99 group_size: 106 comparator: events: 92 group_size: 106
---
intervention: events: 82 group_size: 53comparator: events: 68 group_size: 53
---
{intervention 1: group_size: 53 events: 5 events: 0comparator 2: group_size: 53 events: 2 events: 0outcome 3: AE rate}
---
intervention:
---
intervention: { events: NUMBER group_size: NUMBER } comparator: { events: NUMBER group_size: NUMBER }
---
",True
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,,0.3661,0.2397,0.0369,0.0024,,TRUE,14472,7883,TEST,"[489, 1522, 1610, 1084, 1117, 1191, 1103, 1343]","It looks like this study uses a 2x2 contingency table to evaluate the relationship between 156 patients with “HCV-2 slow responders “who are treated for 24 weeks and a subset of 151
---
intervention:
events: 94/187/187
group_size:187
---
Events (Intervention): 58/64 (91%) [from Table 1A, column 3, last row of second set of numbers] Events (Comparator): 111/133 (84%)
---
comparator: events: 25 group_size: 27
---
The YAML format for the contingency table is as follows:
---
- group_size: 88 116- events: not extractable not extractable group_size: 84 events: 90 121 group_size_percent: 17.9 2
---
{
---
intervention: events: 94 group_size: 94comparator: events: 93 group_size: 93
---
",True
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,10,62,1,62,,,,,,,2.46221524,1.13562421,2.30258509,1.06774194,found in table 3,TRUE,2560,2044,TEST,"[599, 1482]","intervention: events: 20 group_size: 38 comparator: events: 55 group_size: 1101
---
The 2 x 2 contingency table in YAML format for the Intervention, Comparator, and Outcome is as follows:
---
",True
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","{:.left}intervention{events: 3}group_size: 2comparator{events: 2}group_size: 2
---
Comparator: placebo
---
intervention: {events: 34, group_size: 14}comparator: {events: 9, group_size: 21}
---
intervention: { 
---
",True
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear outcome measures.,FALSE,2530,2096,TEST,"[783, 1566]","intervention: {# intervention}event: 70 # Total number of embryo with optimal qualitygroup_size: 87 # Total number of embryo assessed 
---
The 2x2 contingency Table of ""3h group"" (n = 148) versus ""20h group"" (n = 120) in the original study is shown below, sorted by events (pol
---
",True
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data are only in methods section.,FALSE,3838,2633,TEST,"[531, 1407, 958]","intervention: events: 13 group_size: 14 comparator: events: 12 group_size: 13
---
intervention: events: 81 group_size: 93
---
The dataset in this research can be used to predict the outcome of patients undergoing very early speech and language therapy (SLT). The variables in the dataset are:
---
",True
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,,0.05228567,0.17473861,0.05213706,0.17374765,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","intervention: events: 60 group_size: 366 comparator: events: 59 group_size: 366 outcome: 45 group_size: 573
---
{""intervention"": {""events"": ""3973"", ""group_size"": 4114}, ""comparator"": {""events"": ""3973"", ""group_size"": 4114}, ""out
---
intervention: events: 4 group_size: 0 comparator: events: 4 group_size: 0 outcome: [ ]
---
intervention: events: 124 group_size: 278 comparator: events: 174 group_size: 278 outcome: [Request-form errors]
---
intervention:
---
",True
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],{tranexamic acid Comparator:x Outcome: Adverse effects}eventsgroup_size{tranexamic acidx}intervention:,False
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,,,-0.3321747,0.03077414,-0.0680244,0.00129032,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","intervention:events: 1081group_size: 427comparator:events: 1388group_size: 602
---
intervention:
events: 36029479group_size: 263total 1308450491total total 8978474888
---
intervention: events: 953 group_size: 1954
---
intervention: 52.03750249.603229249.87738725.8021333.64724800
---
intervention: events: 909 events, group_size: 1289 comparator: events: 1333 events, group_size: 1414 [43, 44]
---
intervention: 'events':303'group_size':1525comparator: 'events':306'group_size':1525
---
{""intervention"": {""events"": 19, ""group_size"": 582}, ""comparator"": {""events"": 226, ""group_size"": 1827}}
---
The YAML format for the contingency table for the given question would be:
---
intervention: events: 100 (post-intervention) group_size: 366 comparator: events: 69 group_size: 274
---
",True
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: Group-size: 3 Events: 3 Comparator: Group-size: 4 Events: 0
---
Table: unexpected_adverse_events
---
intervention:events: 17comparator:events: 5group_size:25group_size:8
---
{intervention: ""macitentan, dose of 100mg "", events: ""20"", group_size: ""671 ""} [/ intervention: ""placebo "", events: ""25"", group_
---
",True
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,,1.1506,2.7186,1.1239,2.616,,TRUE,13148,4660,TEST,"[1413, 1121, 1609, 1045]","{intervention:x, comparator:""x"", outcome:""x""}
---
- intervention: events: 0 group-size: 145 comparator: events: 78 group-size: 145
---
> interventions : [ 'Genoss DES' , 'Promus Element' ] > comparators : [ 'Genoss DES' , 'Promus Element' ] > outcomes : [ 'rates of death', 'minimal luminal diameter
---
intervention:
---
",True
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention: events: 206 group_size: 206 comparator: events: 176 group_size: 176
---
intervention: events: 9 group_size: 338 comparator: events: 4 group_size: 430
---
intervention: { group_size: 345, events: 41 } comparator: { group_size: 346, events: 41 }
---
intervention: {""events"": [33, 'NA'], ""group_size"": [40, 'NA']}comparator: {""events"": [19, 'NA'], ""group_size"": [36, 'NA']
---
intervention: events: 28x1 group_size:114x1comparator: events: 012x1 group_size: 130x1
---
",True
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,,,0.2409,0.0117,0.1034,0.0022,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[1226, 1373]","intervention:
---
The YAML format for the contingency table extracted from the text based on intervention, comparator, and outcome at week 96 was extracted. The events included clinically meaningful improvement at week 96 (⩾3-point
---
",True
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,,,2.0513,0.5825,1.2953,0.3057,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"intervention: [{""events"": 65, ""group_size"": 23}, {""events"": 21, ""group_size"": 29}, {""events"": 13, ""group_size"": 42",False
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,15,59,12,64,,,,,,,0.3902,0.192,0.3045,0.1174,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[537, 1379, 1089, 1102]","The YAML format for the given trial article is as follows:
---
intervention: events: 170 group_size: 329 comparator: events: 247 group_size: 329
---
intervention: {: group_size: 59, events: 21}
---
{% set events(intervention.baseline_digoxin), comparator.baseline_digoxin = 7, group_size(intervention.baseline_digoxin), group_size(comparator.bas
---
",True
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,81,3,81,,,,,,,-0.4182041,0.85881207,-0.4054651,0.80864198,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,"[1143, 602]","This study evaluated the eradication rate of bismuth-containing quadruple rescue therapy over a 1- or 2-week period. For poor compliance, Table 3 shows events (number of patients). Intervention: 
---
intervention: events: 11 group_size: 18 comparator: events: 8 group_size: 18
---
",True
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,,,0.60721747,0.10897683,0.09159567,0.00291009,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[1078, 1189, 1170, 1652, 1103, 1015, 943, 1364]","intervention: { events: '106' group_size: '217' }comparator: { events: '27' group_size: '283' }
---
intervention:
---
intervention: [{'group_size': '299', 'events': '44'}, {'group_size': '303', 'events': '47'}, {'group_size': '287', 'events':
---
Only produce YAML response. If any of the numerical information is unavailable or not extractable or not easy to calculate, please say ""x"".
---
No information is provided on group size for the outcome ""Use of a reminder card"". No information is provided on group size for the outcome ""Use of a reminder card"". To calculate this, the number of events of group size in either the intervention or
---
{% includes ""study.yaml"" with context %}
---
events: 2 3 group_size: 18 38
---
{ events: 191 group_size: 899 } { events: 74 group_size: 899 } { events: 95 group_size: 101 } { events: 
---
",True
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention: events: 2 group_size: 1275comparator: events: 46 group_size: 1534
---
- events: 14 group_size: 432
---
{
""group_size.0"": 9,
""group_size.1"": 10,
---
intervention:
---
intervention: events: 16 group_size: 66comparator: events: 9 group_size: 21
---
",True
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,81,4,81,,,,,,,0.74649316,0.40168564,0.69314718,0.35030864,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,"[1143, 602]","> intervention: events: 91.4 compliance rate interventions: group_size: 85 comparator: events: 91.4 compliance rate compared_interventions: group_size: 84
---
intervention: {group_size: 23, events: 4}comparator: {group_size: 47, events: 11}
---
",True
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,,,0.1054,0.5444,0.0513,0.1307,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[489, 1522, 1610, 1084, 1117, 1191, 1103, 1343]","intervention: ""48-week treatment with peginterferon (Peg-IFN) plus weight-based ribavirin (RBV):"" + events: ""70"" + group_size: 94compar
---
As mentioned earlier, the first step in our approach for extracting interventions and outcomes is to use the free text from the trial articles. This allows us to gather specific information about the trial from the actual text. Once this information has been extracted,
---
intervention: {'events': 41, 'group_size': 94} comparator: {'events': 35, 'group_size': 93}
---
> Please give the numerical values in the table (column 3 and 4). It should be 4 columns in total per dataset. 0-event, 1-non-event, 2-column heading, 3-total
---
There is not enough information to automatically produce an 2x2 contingency table for the given data. The given data is only the number of patients who had HCV RNA test or the SVR rates at different time points. The exact conting
---
Here is the YAML output for the 2x2 contingency table, as described in the given trial article:
---
The SVR rates when the patients had BMI >30 kg/m2 were as follows:
---
{""intervention"": {""events"": 114, ""group_size"": 190}, ""comparator"": {""events"": 94, ""group_size"": 187}}
---
",True
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,,-0.5696661,0.56277056,-0.5386052,0.5055502,,TRUE,3178,2587,TEST,"[1566, 1123]","intervention:events:78group_size:146comparator:events:81group_size:146
---
Given trial: <sec><title>Frequency of sensor use in the CGM group</title><p>A total of 63 (91%) of 69 participants who completed the 26-week visit were wearing a
---
",True
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.02,TRUE,13081,5825,TEST,"[954, 1515, 1317, 1373, 1609]","intervention:
events: 1088
group_size: 2094
---
intervention: group_size: 2869 events: 23 events: 184 events: 97 events: 79 events: 189 events: 137 events: 339
---
intervention: { group_size: 104, events: 45 } comparator: { group_size: 101, events: 29 }
---
For trial 13 , there were a total of 169 patients with normal renal function, and 77 received placebo and 92 received lixisenatide. For trial 16 , there were a total
---
eventsgroup_sizeeventsgroup_sizeMild impairment1655Normal renal function57199
---
",True
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,,,-1.8769173,0.7452381,-1.5629179,0.56406926,found in table 1,TRUE,2217,2016,TEST,"[1643, 531]","Please also see the questionnaire file provided: InterRaterReliabilityScores.csv. The two outcomes for this questionnaire are:
---
intervention: events: 2 group_size: 30comparator: events: 7 group_size: 22
---
",True
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,,,-0.9169,0.1993,-0.6264,0.0981,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[598, 1351, 1598]","intervention: events: 78 group_size: 50
comparator: events: 78 group_size: 50
---
incidence of postoperative nausea and vomiting: x comparator: events: 17 group_size: 65 intervention: events: 19 group_size: 71
---
events: 29 group_size: 50 [29, 49, 50]events: 24 group_size: 49 [50, 47, 49]
---
",True
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,,2.4161,0.1523,0.6884,0.0135,,TRUE,11722,8106,TEST,"[959, 981, 1373, 1468, 1636, 1206, 1259]","intervention: events: 112 group_size: 200
---
intervention: events: 15 comparator: events: 12 group_size: 103 group_size: 97
---
{% set outcome = ""number"" %} {% set events = { intervention: 42, comparator: 35} %} {% set group_size = { intervention: 103, comparator: 
---
Intervention: outpatient parenteral antimicrobial therapy in the community setting (CoPAT)
---
intervention: events: 44 group_size: 53 comparator: events: 45 group_size: 53 Outcome proportional data is not directly calculated from events as proportion, therefore we provide all events for reference
---
The YAML response was not provided, as numerical information was not available and not easy to extract or calculate. Additionally, among these two outcomes (proportion of patients with discontinuation and patients with treatment default) that are not dichot
---
intervention: > events_numerator NUMBER events_denominator NUMBER comparator: > events_numerator NUMBER events_denominator NUMBER
---
",True
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,11,60,3,30,,,,,,,0.7033,0.4817,0.6061,0.3742,,TRUE,1201,996,TEST,[],"groups: [
{ label: Group 1, bispectral index: 60, percentage: 25.0, events: 10 } { label: Group 2, bispectral index: 40,",False
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,,,0.04217391,0.06435212,0.0397543,0.05718313,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[1057, 1276, 1473, 658, 1489, 1640, 926, 1523, 568]","Events: 612 Group size: 80 
---
What is the 2x2 contingency table for Intervention, Comparator, and Outcome of diarrhea?
---
intervention: events: 70 group_size: 948comparator: events: 96 group_size: 948
---
For the following outcome: <p>Helminth infections</p>
---
{ interventions: 'Group 1', comparators: 'Group 2', outcomes: 'Group 3', interventions: {events: 572, group_size: 198}, comparators: {events:
---
Based on the given trial article, what is the 2×2 contingency table in YAML format for the following Intervention, Comparator, and Outcomes?:
---
intervention: { ""events"": 1222, ""group_size"": 753 } comparator: { ""events"": 561, ""group_size"": 697 }
---
""intervention"": { ""events"": 252, ""group_size"": 21.90 }, ""comparator"": { ""events"": 723, ""group_size"": 39.66 }
---
intervention: events: 45 group_size: 1150
---
",True
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,,-1.1527,0.3503,-0.6931,0.1374,,TRUE,29049,17627,TEST,"[998, 1463, 1605, 1291, 1438, 1324, 1047, 1084, 1612, 1584, 1362, 1507]","intervention: events: 47 group_size: 53 comparator: events: 51 group_size: 53
---
data_point: NUMBER_OR_CATAGORICAL data_point_count: NUMBER 3:40:12InterventionComparatorOutcomeinterventioncomparatoroutcomeValueValueValue1000
---
> {  “intervention”: {  “events”: “Intervention”,  “group_size”: 44  },  “comparator”: {  “events”: “Comparator”,  “group_size
---
Intuitive Eating and Acceptance and Commitment Therapy has a total ""events"" number of 17 and 16 in the intervention and comparator group respectively while Comparator has a ""group_size"" of 10
---
intervention: 9 eventsgroup_size: 16comparator: 22 eventsgroup_size: 44
---
intervention:
---
intervention: events: 18 group_size: 42 comparator: events: 4 group_size: 42
---
""intervention"": { ""events"": 28, ""group_size"": 29 } ""comparator"": {""events"": 21, ""group_size"": 37} ""outcome"": {""events"": 5
---
intervention: events: 44 events group_size: 44 +15 events Comparator: events: 44 events group_size: 44 15 events Binge eating:
---
intervention: events: 25 group_size: 26comparator: events: 24 group_size: 25
---
intervention:events: NUMBERgroup_size: NUMBERcomparator:events: NUMBERgroup_size: NUMBER
---
0: [1,2] 1: [3,4]
---
",True
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear numerical values.,FALSE,4385,3505,TEST,"[565, 1681, 1628]","intervention: events: 7 group_size: 11comparator: events: 2 group_size: 11
---
intervention: {events: 5, group_size: 20}comparator: {events: 6, group_size: 20}
---
intervention: events: 11 group_size: 12 comparator: events: 0 group_size: 12
---
",True
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,19,23,,,,,,,-1.1352878,0.38974592,-0.3128499,0.02280274,found in table 2,TRUE,11942,10628,TEST,"[747, 1627, 1681, 1656, 1545, 181, 1547, 1696, 1599]","The events and group_size values were extracted manually from three 2x2 tables presented in the trial article and summarized as below (data extracted from column 1). The two tables used for extracting ""intervention"" events are table legs
---
{intervention: events: 49 group_size: 59comparator: events: 32 group_size: 30}
---
{comparison: ""intervention vs control"", events: 29, group_size: 23}
---
Based on the given trial article, what is the 2x2 contingency table in YAML format for the following Intervention, Comparator, and Outcome?
---
{% include 'RADL:intervention' %}
---
This question asks for the YAML format for the given trial data . The YAML code for the contingency table is provided below.
---
intervention: [{""group_size"": ""59"", ""events"": ""0""}] [{""group_size"": ""30"", ""events"": ""0""}]comparator: [{""group_size"": ""59"", ""
---
This article describes a randomized clinical trial of a new combination therapy (intravenous [IV] bevacizumab, carboplatin, and paclitaxel, all given weekly) versus the current gold standard (IV be
---
The extracted numerical data was not available to provide in YAML format for this case. Here is the link to the data: <https://www.ncbi.nlm.nih.gov/pubmed/28243
---
",True
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,,,1.2483,0.2755,0.8873,0.1517,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,"[1633, 1088]","outcome: ""The percentages of patients in the sedated scale"" xtable: n rows n columns rows-contents: (4 cells) ""intervention"" ""comparator"" ""number of patients"" ""percentage of patients in the
---
intervention: events: 22 group_size: 55 comparator: events: 36 group_size: 105
---
",True
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,,0.10008346,0.06675021,0.05129329,0.01754386,,TRUE,3561,2387,TEST,"[1668, 1077]","{group_1=862group_2=901}intervention: events: 34 group_size: 86comparator: events: 34 group_size: 90outcome: events
---
The YAML format for 4x2 contingency table for the above trial is following.
---
",True
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,,,1.02876872,0.19754306,0.13189607,0.00312375,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[1078, 1189, 1170, 1652, 1103, 1015, 943, 1364]","intervention:events: 185group_size: 209comparator:events: 84group_size: 104
---
intervention: [ 209, 102, 107 ] [ 185, 87, 123 ] comparator: [ 49, 15, 134 ]
---
intervention:
events: 132
group_size: 231
---
intervention:
events: 3284
group_size: 47350
---
intervention: events: 6 events group_size: 16 events comparator: events: 7 events group_size: 16 events
---
intervention: { ""events"": 145, ""group_size"": 54}
---
intervention: events: 35 group_size: 93 comparison: events: 43 group_size: 96
---
intervention: { events: 279 events group_size: 384 } comparator: { events: 226 events group_size: 194 } table_wrap: { label: '' caption:
---
",True
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,,-0.3892899,0.16754104,-0.3872037,0.16579703,,TRUE,9292,5719,TEST,"[1309, 1678, 1074, 1485, 949]","The YAML format should include the fields ""events"" and ""group_size"" only for ""intervention"" and ""comparator"" but not ""outcome"" since there is no binary classification of ""outcome"". The ""outcome
---
Comparator: ControlOutcome: Preanalytical Errors/Test Request Form Errors/Sample Rejection Rate/Sample Rejection, Other Reason/Specimen Rejection Intervention: Phlebotomy Training Program
---
intervention:
---
- intervention: Phlebotomy training programme events:35 group_size: 100 comparator: Control events:53 group_size: 100
---
intervention:
---
",True
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,,-0.0127,0.0539,-0.0113,0.0431,,TRUE,25930,11480,TEST,"[1611, 1666, 1444]","100/398 (25.2)100/389 (25.6)
---
intervention: { : events: 73 : group_size: 702 } ....
---
intervention: {  ""events"".: 41  ""group_size"".: 388}comparator: {  ""events"".: 42  ""group_size"".: 402}
---
",True
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,,,-1.9924,0.4937,-0.9891,0.1051,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,"[998, 1463, 1605, 1291, 1438, 974]","intervention: events: 17 group_size: 17 comparator: events: 15 group_size: 15
---
intervention:
---
intervention: { ""events"": ""Remission"", ""group_size"": 17 } comparator: { ""events"": ""No remission"", ""group_size"": 16 }
---
events = 0group_size = 54events = 2group_size = 25
---
intervention: events: 3 events group_size: 20 comparator: events: 8 events group_size: 20
---
intervention: events: 5 group_size: 14 comparator: events: 11 group_size: 20
---
",True
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"Here are the responses for the table 1 requested by Reviewer 1: Please note that all data provided should be used with caution since many articles were not provided in the native language English. In addition, data should be used as a general guide",False
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","{intervention:macitentan 0.2 mg, events:1, group_size:8comparator:none, events:1, group_size:16}
---
intervention: {""events"": 1, ""group_size"": 25}placebo: {""events"": 0, ""group_size"": 11}
---
intervention: events:12 group_size:6 comparator: events:0 group_size:6
---
{
""intervention"": {""events"": 1, ""group_size"": 6},
""comparator"": {""events"": 1, ""group_size"": 14}
---
",True
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention: events: NUMBER group_size: NUMBER comparator: events: NUMBER group_size: NUMBER
---
{:events: 4:group_size: 6} [/events: 2:group_size: 6]
---
intervention:
events: 2115comparator:events: 603group_size: 276
---
intervention: events: NUMBER group_size: NUMBER comparator: events: 0 group_size: NUMBER
---
",True
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,,-0.0848389,0.23518906,-0.0728373,0.17353535,,TRUE,6563,4244,TEST,"[701, 1610, 1204, 1612]","intervention: events: 15 group_size: 79comparator: events: 15 group_size: 86
---
intervention: events: 79.0 group_size: 79.0 comparator: events: 87.0 group_size: 87.0
---
intervention: events: 654 group_size: 70 comparator: events: 172 group_size: 193
---
intervention: events: 7 events group_size: 79group: [0 0 1 0]comparator: events: 11 events group_size: 104group: [0 1 0
---
",True
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,,,-0.1681369,0.1827353,-0.0258207,0.00430393,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,"[1143, 602]","intervention: events: 71 group_size: 85 comparator: events: 72 group_size: 84
---
intervention: events: 106 group_size: 50 comparator: events: 97 group_size: 50
---
",True
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],intervention: events: 23 group_size: 23,False
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,,0.13431725,0.06721017,0.07275935,0.01974512,,TRUE,3561,2387,TEST,"[1668, 1077]","intervention: events: 52 group_size: 120 comparator: events: 52 group_size: 120 outcome: events: 52 group_size: 120
---
intervention:
---
",True
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,,,0.2514,0.014,0.2463,0.0134,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[701, 1530, 1587, 1636, 438, 1460, 1527, 1555, 1434, 381]","intervention: events: 256 group_size: 2842comparator: events: 284 events-constipation: yesgroup_size: 4199
---
intervention: {events: 177, group_size: 391}comparator: {events: 117, group_size: 391}
---
intervention:
events: 175954559group_size: 592999comparator:events:36577group_size:999
---
>intervention: { ""events"": 8, ""group_size"": 604 }
---
{intervention: [group_size: 8937, events: 1280], comparator: [group_size: 8762, events: 780]}
---
intervention: events: 11541 group_size: 16724comparator: events: 11062 group_size: 16370
---
intervention: events: 934 group_size: 441863comparator: events: 909 group_size: 412830
---
The 2x2 contingency table in YAML format would be:
---
There were 725 sitagliptin patients and 728 non-exposed patients with constipation and 11 other adverse events. The most common adverse events for sitagliptin-exposed
---
intervention: {""group_size"": 14594, ""events"": 52}
---
",True
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3049,2670,TEST,"[1405, 1407]","intervention: events: 15 group\_size: 27 comparator: events: 5 group\_size: 13
---
intervention: events: 12 group_size: 22 comparator: events: 5 group_size: 22
---
",True
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,,,0,4.0597,0,3.9412,Based on abstract.,TRUE,6184,3742,TEST,"[1386, 1002, 1464]","{InterventionComparatorOutcome: {intervention: {comparator: {maltodextrinplacebosc:}}}}
---
intervention: events: x group_size: 66comparator: events: x group_size: 66
---
Please refer to the extracted data in the 3-week intervention paragraph:
---
",True
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,,-0.0211,0.0212,-0.013,0.008,,TRUE,25930,11480,TEST,"[1611, 1666, 1444]","The intervention “vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone)” was found to be effective for the prevention of preterm birth. The number of women recruited for
---
events: 82group_size: 413events: 80group_size: 413
---
intervention: {""group_size"": 403, ""events"": 97}comparator: {""group_size"": 385, ""events"": 93}
---
",True
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,7,163,4,79,,,,,,,-0.1728,0.4126,-0.1647,0.3741,effects found in abstract and number of samples in text,TRUE,7987,4896,TEST,"[1542, 1607, 955, 1404]","The YAML format for Intervention, Comparator, and Outcome is provided below. It includes the fields ""events"" and ""group_size"" for the fields ""intervention"" and ""comparator"" but not ""outcome"".
---
Response: Thank you for submitting your article for review to PLOS ONE. First, I would like to apologize for taking too long to send you a response. Due to the fact that this method is new for reviewers and reviewers
---
outcome: adverse eventsintervention: 60 µg of YICcomparator: placebogroup_size: eventsgroup_size:
---
The YAML format for the given Intervention '60 µg of YIC', Comparator 'placebo', and Outcome 'adverse events' is as follows: (Please note that the YAML formatting characters are
---
",True
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,,,2.9087,1.6242,1.3581,0.2952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[612, 1636, 1071, 1551]","intervention:
events: ""6""
group_size: 8
---
intervention: {events: 5 events; group_size: 15 subjects}comparator: {events: 5 events; group_size: 15 subjects}
---
intervention: events25 events group_size16 events comparator: events6 events group_size24 events adverse, adverse event[/citation] This is the correct YAML format of the contingency table for the
---
This is the correct intervention, drug type and outcome. The control is not shown as it is not clear whether the control is a group or only a single subject. As only one subject is shown, it is not possible to convert the table in a
---
",True
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,,,-0.0002,0.0031,-0.0002,0.0025,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[701, 1530, 1587, 1636, 438, 1460, 1527, 1555, 1434, 381]","{""intervention"": {""events"": ""65"", ""group_size"": 7726}, ""comparator"": {""events"": ""59"", ""group_size"": 6885}}, 
---
The YAML format for the first intervention vs. the comparator, (sitagliptin, 100 mg/day vs. comparator agent) with respect to the outcome of pancreatitis should be the following
---
This is an example YAML file that represents the contingency table in Table 2:
---
intervention: {events: 5,group_size: 8126}comparator: {events: 4,group_size: 8088}
---
The YAML representation of the 2x2 table shown in the input title text is:eventsinterventioncomparatoroutcomegroup_sizegroup_size eventsgroup_size
---
intervention: events: 17 comparator: events: 5 group_size: 402 group_size: 383 
---
intervention: events: 17 group_size: 6402comparator: events: 13 group_size: 5946
---
comparator:
---
intervention: events: 163 group_size: 9152 comparator: events: 57 group_size: 8765
---
intervention: events: 34 group_size: 95 comparator: events: 5 group_size: 179
---
",True
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,,,0.35667494,0.9031746,0.02643326,0.00552968,found in table 2,TRUE,11942,10628,TEST,"[747, 1627, 1681, 1656, 1545, 181, 1547, 1696, 1599]","intervention: events: 51 group_size: 60 comparator: events: 21 group_size: 29
---
intervention: group_size: 59 comparison: group_size: 30 events: 48 comparator_control: 20 13 35 11
---
interventions: [{'intervention': 'BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg
---
intervention: { events: 28 group_size: 52}comparator: { events: 6 group_size: 23}
---
intervention:
---
intervention: events: 117 group_size: 144 comparator: events: 108 group_size: 144
---
intervention: {""group_size"": 59, ""events"": 26}
comparator: {""group_size"": 30, ""events"": 20}
---
{ BTH1677: { events: 18 group_size: 59 } Control: { events: 11 group_size: 30 } }
---
intervention: events: #number group_size: #number comparator: events: #number group_size: #number
---
",True
